zongyuan yang - Search Results

Year	Number of Results
2013	3
2014	3
2015	2
2016	3
2017	6
2018	5
2019	7
2020	1
2021	3
2022	1
2023	1
2024	0

1

TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.

Wei X, Lou H, Zhou D, Jia Y, Li H, Huang Q, Ma J, Yang Z, Sun C, Meng Y, Xu S, Yang X, Li X, Ji T, Guo Z, Gao Q. Wei X, et al. Among authors: yang z. J Exp Clin Cancer Res. 2021 Sep 19;40(1):292. doi: 10.1186/s13046-021-02091-6. J Exp Clin Cancer Res. 2021. PMID: 34538264 Free PMC article.

2

Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB-Triggered SASP in Cancer-Associated Fibroblasts.

Jin P, Li X, Xia Y, Li H, Li X, Yang ZY, Wang Z, Xu C, Fang T, Zhou D, Xiong X, Wang SY, Xu S, Gao Q. Jin P, et al. Mol Cancer Ther. 2023 Apr 3;22(4):447-458. doi: 10.1158/1535-7163.MCT-22-0396. Mol Cancer Ther. 2023. PMID: 36780236

3

Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.

Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, Liu Y, Zhou X, Zhang T, Gong C, Wei X, Liu D, Sun C, Chen G, Hu J, Meng L, Zhou J, Sawada K, Fruscio R, Grunt TW, Wischhusen J, Vargas-Hernández VM, Pothuri B, Coleman RL. Gao Q, et al. Among authors: yang z. J Exp Med. 2019 Mar 4;216(3):688-703. doi: 10.1084/jem.20180765. Epub 2019 Feb 1. J Exp Med. 2019. PMID: 30710055 Free PMC article.

4

Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.

Wang Y, Qiao L, Yang J, Li X, Duan Y, Liu J, Chen S, Li H, Liu D, Fang T, Ma J, Li X, Ye F, Wan J, Wei J, Xu Q, Guo E, Jin P, Wu M, Zhang L, Xia Y, Wu Y, Shao J, Feng Y, Zhang Q, Yang Z, Chen G, Zhang Q, Li X, Wang S, Hu J, Wang X, Tan MP, Takabe K, Kong B, Yang Q, Ma D, Gao Q. Wang Y, et al. Among authors: yang z. Cancer Commun (Lond). 2021 Dec;41(12):1373-1386. doi: 10.1002/cac2.12233. Epub 2021 Nov 5. Cancer Commun (Lond). 2021. PMID: 34738326 Free PMC article.

5

The structural and functional characteristics of soluble dietary fibers modified from tomato pomace with increased content of lycopene.

Li J, Yang Z, Zhang Y, Gao B, Niu Y, Lucy Yu L. Li J, et al. Among authors: yang z. Food Chem. 2022 Jul 15;382:132333. doi: 10.1016/j.foodchem.2022.132333. Epub 2022 Feb 3. Food Chem. 2022. PMID: 35149462

6

C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.

Liu D, Zhang XX, Li MC, Cao CH, Wan DY, Xi BX, Tan JH, Wang J, Yang ZY, Feng XX, Ye F, Chen G, Wu P, Xi L, Wang H, Zhou JF, Feng ZH, Ma D, Gao QL. Liu D, et al. Nat Commun. 2018 Apr 30;9(1):1739. doi: 10.1038/s41467-018-03590-5. Nat Commun. 2018. PMID: 29712898 Free PMC article.

7

Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer.

Yang Z, Jin P, Xu S, Zhang T, Yang X, Li X, Wei X, Sun C, Chen G, Ma D, Gao Q. Yang Z, et al. Cancer Lett. 2018 Feb 28;415:20-29. doi: 10.1016/j.canlet.2017.11.026. Epub 2017 Dec 1. Cancer Lett. 2018. PMID: 29199004 Free article.

8

PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer.

Li X, Fang T, Xu S, Jin P, Zhou D, Wang Z, Li H, Yang Z, Chen G, Zheng X, Xia Y, Wei X, Zhang Z, Yang X, Wang Y, Gao Q. Li X, et al. Among authors: yang z. NPJ Precis Oncol. 2021 Jun 9;5(1):49. doi: 10.1038/s41698-021-00189-w. NPJ Precis Oncol. 2021. PMID: 34108603 Free PMC article.

9

Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer.

Xu S, Yang Z, Jin P, Yang X, Li X, Wei X, Wang Y, Long S, Zhang T, Chen G, Sun C, Ma D, Gao Q. Xu S, et al. Among authors: yang z. Mol Cancer Ther. 2018 Jun;17(6):1291-1302. doi: 10.1158/1535-7163.MCT-17-0927. Epub 2018 Mar 15. Mol Cancer Ther. 2018. PMID: 29545331

10

Mechanical cues modulate cellular uptake of nanoparticles in cancer via clathrin-mediated and caveolae-mediated endocytosis pathways.

Wei X, Wei R, Jiang G, Jia Y, Lou H, Yang Z, Luo D, Huang Q, Xu S, Yang X, Zhou Y, Li X, Ji T, Hu J, Xi L, Ma D, Ye F, Gao Q. Wei X, et al. Among authors: yang z. Nanomedicine (Lond). 2019 Mar;14(5):613-626. doi: 10.2217/nnm-2018-0334. Epub 2019 Feb 28. Nanomedicine (Lond). 2019. PMID: 30816057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year